New Zealand gives provisional nod to AstraZeneca's COVID-19 vaccine
- Country:
- New Zealand
New Zealand's health regulator Medsafe has granted provisional approval for the AstraZeneca COVID-19 vaccine for individuals 18 years of age and older, acting minister for COVID-19 response, Dr Ayesha Verrall, said on Thursday.
New Zealand secured 7.6 million doses of the AstraZeneca COVID-19 vaccine through an advance purchase agreement with the company last year.
The country has only been using the Pfizer/BioNTech COVID-19 vaccine so far.
ALSO READ
-
New Zealand Gives NZ$300,000 to Help Developing Countries Build Safer Food Trade
-
Potential EU Partnerships Stir International Debate
-
New Zealand Denies EU Association Talks
-
New Zealand's Stance on EU Association
-
Global Health Updates: ByteDance AI Spin-off, Cancer Drug Expansion, and Vaccine Challenges
Google News